Stroke Ready - Optimizing Acute Stroke Care
NCT03645590 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5970
Last updated 2026-05-01
Summary
The study aims to increase acute stroke treatment rates in Flint, Michigan through a two-pronged approach of hospital and community level interventions. It also aims to inform future stroke preparedness interventions by exploring the relative importance of hospital optimization and community interventions.
Conditions
- Stroke, Acute
- Stroke
Interventions
- BEHAVIORAL
-
Stroke Ready
Stroke Ready community intervention consists of peer facilitated educational workshops, stroke music video, and mass media campaign including print materials (e.g. posters, brochure), health promotion mailers, radio/Television public health service announcements, and the Stroke Ready website and Facebook page.
Sponsors & Collaborators
-
National Institute on Minority Health and Health Disparities (NIMHD)
collaborator NIH - lead OTHER
Principal Investigators
-
Lesli Skolarus, MD · University of Michigan
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-20
- Primary Completion
- 2021-03-31
- Completion
- 2021-03-31
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers of Acute Stroke in Clinic
NCT03897478 ·Status: UNKNOWN
-
A Study of Survival and Outcome After Stroke
NCT01193569 ·Status: COMPLETED
-
Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE
NCT05762146 ·Status: RECRUITING ·Phase: PHASE2
-
Personalized Antiplatelet Secondary Stroke PRevenTion
NCT03979781 ·Status: COMPLETED ·Phase: PHASE2
-
REcurrent Stroke Prevention Through Personalized Education by Clinical Trainers (RESPPECT Trial)
NCT03861494 ·Status: COMPLETED ·Phase: NA
-
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
NCT04242784 ·Status: COMPLETED
-
Study of Procoagulation Markers in Stroke Patients
NCT01811550 ·Status: COMPLETED
-
Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing
NCT06943586 ·Status: RECRUITING ·Phase: NA
-
Mobile Terminal Based Management of Stroke Secondary Prevention Adminstration Effect Research
NCT02618265 ·Status: UNKNOWN ·Phase: NA
-
THE IMPACT- 24M TRIAL (IMPlant Augmenting Cerebral Blood Flow in Mild Strokes Trial 24 Hours From Stroke Onset)
NCT03551093 ·Status: COMPLETED ·Phase: NA
-
SMARTCap Stroke Study: A Field Deployable Blood Test for Stroke
NCT02308605 ·Status: COMPLETED
-
StroCare - Optimised Cross-sectoral,Coordinated Treatment of Stroke Patients With Patient-orientated Outcome Measurement
NCT04159324 ·Status: COMPLETED ·Phase: NA
-
Pulse Endovascular ReperFUSION for Acute Ischemic Stroke
NCT06052969 ·Status: RECRUITING ·Phase: NA
-
Interventional Management of Stroke (IMS) II Study
NCT00243906 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator
NCT01006993 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke
NCT01133223 ·Status: WITHDRAWN ·Phase: PHASE2
-
Imaging Guided Patient Selection for Interventional Revascularization Therapy
NCT00963989 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Safety and Effectiveness of the Penumbra System
NCT00334061 ·Status: COMPLETED ·Phase: PHASE2
-
Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack
NCT00931788 ·Status: COMPLETED ·Phase: PHASE4
-
Intensified Secondary Prevention Intending a Reduction of Recurrent Events in TIA and Minor Stroke Patients
NCT01586702 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Fluoxetine - a Trial in Stroke
NCT02683213 ·Status: COMPLETED ·Phase: PHASE3
-
Midodrine for Ischemic Stroke With Penumbra
NCT02383121 ·Status: WITHDRAWN
-
Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke
NCT00894803 ·Status: COMPLETED ·Phase: PHASE2
-
HT-3951 vs. Placebo in Stroke Rehabilitation
NCT02530307 ·Status: TERMINATED ·Phase: PHASE2
-
Standard Medical Management in Secondary Prevention of Ischemic Stroke in China
NCT00664846 ·Status: COMPLETED ·Phase: NA